Jefferies Group LLC Neurocrine Biosciences Inc Put Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $1.81 Million - $2.37 Million	-25,000 Closed	0 $0
Q3 2021 Sep 21, 2023	SELL	$86.18 - $99.03 $2.15 Million - $2.48 Million	-25,000 Reduced 50.0%	25,000 $2.4 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $2.15 Million - $2.48 Million	-25,000 Reduced 50.0%	25,000 $2.4 Million
Q2 2021 Aug 20, 2021	SELL	$89.43 - $102.27 $443 Million - $506 Million	-4,950,000 Reduced 99.0%	50,000 $4.87 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $443 Million - $506 Million	4,950,000 Added 9900.0%	5,000,000 $4.87 Million
Q1 2021 Sep 21, 2023	BUY	$87.57 - $119.4 $4.16 Million - $5.67 Million	47,500 Added 1900.0%	50,000 $4.86 Million
Q1 2021 May 14, 2021	BUY	$87.57 - $119.4 $4.16 Million - $5.67 Million	47,500 Added 1900.0%	50,000 $4.86 Million
Q4 2020 Sep 21, 2023	BUY	$86.91 - $108.33 $217,275 - $270,825	2,500 New	2,500 $239,000
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $6.3 Million - $7.85 Million	-72,500 Reduced 96.67%	2,500 $240,000
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $1.44 Million - $2.03 Million	-15,000 Reduced 16.67%	75,000 $7.21 Million
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $1.49 Million - $2.28 Million	17,500 Added 24.14%	90,000 $11 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $3.57 Million - $5.4 Million	47,500 Added 190.0%	72,500 $6.28 Million
Q4 2019 Feb 13, 2020	SELL	$86.8 - $118.57 $10.7 Million - $14.6 Million	-123,300 Reduced 83.14%	25,000 $2.69 Million
Q3 2019 Nov 13, 2019	BUY	$83.82 - $101.5 $5.03 Million - $6.09 Million	60,000 Added 67.95%	148,300 $13.4 Million
Q1 2019 May 15, 2019	SELL	$69.31 - $91.53 $2.6 Million - $3.43 Million	-37,500 Reduced 29.81%	88,300 $7.78 Million
Q4 2018 Feb 14, 2019	BUY	$68.32 - $124.36 $5.86 Million - $10.7 Million	85,700 Added 213.72%	125,800 $8.98 Million
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $3.97 Million - $5.05 Million	40,100 New	40,100 $4.93 Million

Others Institutions Holding NBIX

# of Institutions

627

Shares Held

94.3M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.82 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.28 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$659 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$329 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$238 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account